Tahir Amin is a founder and CEO of the Initiative for Medicines, Access & Knowledge (I-MAK). He has spent over two decades working in the global access to medicines movement addressing the systemic inequities in how medicines are developed and distributed, and he has over 30 years of experience in the field of intellectual property (IP), during which he practiced as an attorney with two of the leading law firms in the UK and for multinational corporations. His work focuses on changing the structural power dynamics that allow economic and health inequities to persist by challenging and re-shaping IP laws and the related global political economy to better serve the public interest. He is a former Harvard Medical School Fellow in the Department of Global Health & Social Medicine and has served as legal advisor/consultant to many international groups, including the European Patent Office World Health Organization and Unitaid, as well as testifying before the U.S. Congress on intellectual property and unsustainable drug prices. Tahir currently serves on New York City Mayor, Zohran Mamdani’s Transition Committee on Health.